MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4330/wjc.v11.i4.126

Медицинская библиотека · World journal of cardiology · 2019

Who benefits from percutaneous closure of patent foramen ovale vs medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials.

Dahal Khagendra, Yousuf Adil, Watti Hussam, Liang Brannen, Sharma Sharan, Rijal Jharendra, Katikaneni Pavan, Modi Kalgi, Tandon Neeraj, Azrin Michael, Lee Juyong

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

A few randomized clinical trials (RCT) and their meta-analyses have found patent foramen ovale closure (PFOC) to be beneficial in prevention of stroke compared to medical therapy. Whether the benefit is extended across all groups of patients remains unclear.

AIM: To evaluate the efficacy and safety of PFOC vs medical therapy in different groups of patients presenting with stroke, we performed this meta-analysis of RCTs.

METHODS

Electronic search of PubMed, EMBASE, Cochrane Central, CINAHL and ProQuest Central and manual search were performed from inception through September 2018 for RCTs. Ischemic stroke (IS), transient ischemic attack (TIA), a composite of IS, TIA and systemic embolism (SE), mortality, major bleeding, atrial fibrillation (AF) and procedural complications were the major outcomes. Random-effects model was used to perform analyses.

RESULTS

Meta-analysis of 6 RCTs including 3560 patients showed that the PFOC, compared to medical therapy reduced the risk of IS [odds ratio: 0.34; 95% confidence interval: 0.15-0.78; P = 0.01] and the composite of IS, TIA and SE [0.55 (0.32-0.93); P = 0.02] and increased the AF risk [4.79 (2.35-9.77); P < 0.0001]. No statistical difference was observed in the risk of TIA [0.86 (0.54-1.38); P = 0.54], mortality [0.74 (0.28-1.93); P = 0.53] and major bleeding [0.81 (0.42-1.56); P = 0.53] between two strategies. Subgroup analyses showed that compared to medical therapy, PFOC reduced the risk of stroke in persons who were males, ≤ 45 years of age and had large shunt or atrial septal aneurysm.

CONCLUSION

In certain groups of patients presenting with stroke, PFOC is beneficial in preventing future stroke compared to medical therapy.

Для цитирования: Dahal Khagendra, Yousuf Adil, Watti Hussam, Liang Brannen, Sharma Sharan, Rijal Jharendra, Katikaneni Pavan, Modi Kalgi, Tandon Neeraj, Azrin Michael, Lee Juyong. Who benefits from percutaneous closure of patent foramen ovale vs medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials.. World journal of cardiology. 2019. DOI: 10.4330/wjc.v11.i4.126.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.